Evidence for HIV-1 cure after CCR5Δ32/Δ32 allogeneic haemopoietic stem-cell transplantation 30 months post analytical treatment interruption: a case report.
Journal
The lancet. HIV
ISSN: 2352-3018
Titre abrégé: Lancet HIV
Pays: Netherlands
ID NLM: 101645355
Informations de publication
Date de publication:
05 2020
05 2020
Historique:
received:
03
02
2020
revised:
17
02
2020
accepted:
19
02
2020
pubmed:
15
3
2020
medline:
1
9
2020
entrez:
15
3
2020
Statut:
ppublish
Résumé
The London patient (participant 36 in the IciStem cohort) underwent allogeneic stem-cell transplantation with cells that did not express CCR5 (CCR5Δ32/Δ32); remission was reported at 18 months after analytical treatment interruption (ATI). Here, we present longer term data for this patient (up to 30 months after ATI), including sampling from diverse HIV-1 reservoir sites. We used ultrasensitive viral load assays of plasma, semen, and cerebrospinal fluid (CSF) samples to detect HIV-1 RNA. In gut biopsy samples and lymph-node tissue, cell-copy number and total HIV-1 DNA levels were quantified in multiple replicates, using droplet digital PCR (ddPCR) and quantitative real-time PCR. We also analysed the presence of intact proviral DNA using multiplex ddPCR targeting the packaging signal (ψ) and envelope (env). We did intracellular cytokine staining to measure HIV-1-specific T-cell responses. We used low-sensitive and low-avidity antibody assays to measure the humoral response to HIV-1. We predicted the probability of rebound using a mathematical model and inference approach. HIV-1 viral load in plasma remained undetectable in the London patient up to 30 months (last tested on March 4, 2020), using an assay with a detection limit of 1 copy per mL. The patient's CD4 count was 430 cells per μL (23·5% of total T cells) at 28 months. A very low-level positive signal for HIV-1 DNA was recorded in peripheral CD4 memory cells at 28 months. The viral load in semen was undetectable in both plasma (lower limit of detection [LLD] <12 copies per mL) and cells (LLD 10 copies per 10 The London patient has been in HIV-1 remission for 30 months with no detectable replication-competent virus in blood, CSF, intestinal tissue, or lymphoid tissue. Donor chimerism has been maintained at 99% in peripheral T cells. We propose that these findings represent HIV-1 cure. Wellcome Trust and amfAR (American Foundation for AIDS Research).
Sections du résumé
BACKGROUND
The London patient (participant 36 in the IciStem cohort) underwent allogeneic stem-cell transplantation with cells that did not express CCR5 (CCR5Δ32/Δ32); remission was reported at 18 months after analytical treatment interruption (ATI). Here, we present longer term data for this patient (up to 30 months after ATI), including sampling from diverse HIV-1 reservoir sites.
METHODS
We used ultrasensitive viral load assays of plasma, semen, and cerebrospinal fluid (CSF) samples to detect HIV-1 RNA. In gut biopsy samples and lymph-node tissue, cell-copy number and total HIV-1 DNA levels were quantified in multiple replicates, using droplet digital PCR (ddPCR) and quantitative real-time PCR. We also analysed the presence of intact proviral DNA using multiplex ddPCR targeting the packaging signal (ψ) and envelope (env). We did intracellular cytokine staining to measure HIV-1-specific T-cell responses. We used low-sensitive and low-avidity antibody assays to measure the humoral response to HIV-1. We predicted the probability of rebound using a mathematical model and inference approach.
FINDINGS
HIV-1 viral load in plasma remained undetectable in the London patient up to 30 months (last tested on March 4, 2020), using an assay with a detection limit of 1 copy per mL. The patient's CD4 count was 430 cells per μL (23·5% of total T cells) at 28 months. A very low-level positive signal for HIV-1 DNA was recorded in peripheral CD4 memory cells at 28 months. The viral load in semen was undetectable in both plasma (lower limit of detection [LLD] <12 copies per mL) and cells (LLD 10 copies per 10
INTERPRETATION
The London patient has been in HIV-1 remission for 30 months with no detectable replication-competent virus in blood, CSF, intestinal tissue, or lymphoid tissue. Donor chimerism has been maintained at 99% in peripheral T cells. We propose that these findings represent HIV-1 cure.
FUNDING
Wellcome Trust and amfAR (American Foundation for AIDS Research).
Identifiants
pubmed: 32169158
pii: S2352-3018(20)30069-2
doi: 10.1016/S2352-3018(20)30069-2
pmc: PMC7606918
pii:
doi:
Substances chimiques
CCR5 protein, human
0
Receptors, CCR5
0
Types de publication
Case Reports
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e340-e347Subventions
Organisme : Medical Research Council
ID : MRM008614/2
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/R008698/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/L006588/1
Pays : United Kingdom
Organisme : Wellcome Trust
ID : WT108082AIA
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/N001265/1
Pays : United Kingdom
Commentaires et corrections
Type : CommentIn
Informations de copyright
Copyright © 2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved.
Références
Curr Opin Infect Dis. 2013 Dec;26(6):561-6
pubmed: 24152764
N Engl J Med. 2014 Aug 28;371(9):880-2
pubmed: 25162903
PLoS Pathog. 2016 Apr 27;12(4):e1005535
pubmed: 27119536
Biol Blood Marrow Transplant. 2009 Jan;15(1 Suppl):104-13
pubmed: 19147088
Nat Med. 2017 Nov;23(11):1271-1276
pubmed: 28967921
N Engl J Med. 2019 Sep 26;381(13):1240-1247
pubmed: 31509667
EMBO J. 2017 Mar 1;36(5):604-616
pubmed: 28122869
Nature. 2019 Apr;568(7751):244-248
pubmed: 30836379
J Clin Microbiol. 2012 Dec;50(12):3968-76
pubmed: 23035182
Clin Infect Dis. 2011 Apr 1;52(7):911-6
pubmed: 21427399
Mucosal Immunol. 2019 Sep;12(5):1212-1219
pubmed: 31239514
AIDS. 2011 Jan 14;25(2):273-4
pubmed: 21173593
N Engl J Med. 2014 Mar 6;370(10):901-10
pubmed: 24597865
Brain Sci. 2018 Oct 20;8(10):
pubmed: 30347806
Cell Host Microbe. 2014 Dec 10;16(6):711-21
pubmed: 25467409
N Engl J Med. 2009 Feb 12;360(7):692-8
pubmed: 19213682
Blood. 2011 Mar 10;117(10):2791-9
pubmed: 21148083
PLoS Pathog. 2013;9(5):e1003347
pubmed: 23671416
Nature. 2019 Dec;576(7787):397-405
pubmed: 31853080
Sci Rep. 2018 Mar 7;8(1):4153
pubmed: 29515139
Science. 2011 Jun 10;332(6035):1284-8
pubmed: 21566158
EMBO J. 2018 Jan 4;37(1):50-62
pubmed: 29084722
Enferm Infecc Microbiol Clin. 2015 Apr;33(4):238-42
pubmed: 25060663
PLoS Med. 2017 Nov 7;14(11):e1002417
pubmed: 29112956
Nature. 2019 Feb;566(7742):120-125
pubmed: 30700913
Clin Infect Dis. 2017 Apr 15;64(8):1059-1065
pubmed: 28329096
Ann Intern Med. 2014 Sep 2;161(5):319-27
pubmed: 25047577
Proc Natl Acad Sci U S A. 2014 Sep 16;111(37):13475-80
pubmed: 25097264
AIDS. 2014 Jan 28;28(3):439-42
pubmed: 24322272
Lancet HIV. 2015 Jun;2(6):e236-42
pubmed: 26423196
Ann Intern Med. 2018 Nov 20;169(10):674-683
pubmed: 30326031